MAIA Biotechnology, Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q2 2021 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
MAIA Biotechnology, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q2 2021 to Q3 2024.
  • MAIA Biotechnology, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $455K, a 20.2% decline year-over-year.
  • MAIA Biotechnology, Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $2.58M, a 16.5% increase year-over-year.
  • MAIA Biotechnology, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $3.09M, a 33.2% increase from 2022.
  • MAIA Biotechnology, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $2.32M, a 14.8% decline from 2021.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $2.58M $455K -$116K -20.2% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-12
Q2 2024 $2.7M $414K -$205K -33.1% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-09
Q1 2024 $2.9M $350K -$188K -34.9% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q4 2023 $3.09M $1.36M +$873K +179% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-21
Q3 2023 $2.22M $571K +$38.5K +7.23% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 $2.18M $619K +$34.2K +5.84% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-09
Q1 2023 $2.14M $538K -$176K -24.6% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q4 2022 $2.32M $489K Oct 1, 2022 Dec 31, 2022 10-K 2024-03-21
Q3 2022 $532K -$246K -31.6% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 $585K -$192K -24.8% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 $713K Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-08
Q3 2021 $779K Jul 1, 2021 Sep 30, 2021 10-Q/A 2023-02-06
Q2 2021 $777K Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-22
* An asterisk sign (*) next to the value indicates that the value is likely invalid.